Smith-Midland Corp. (NASDAQ:SMID - Get Free Report)'s stock price fell 1% during mid-day trading on Tuesday . The company traded as low as $29.65 and last traded at $29.65. 13,002 shares traded hands during mid-day trading, an increase of 52% from the average session volume of 8,575 shares. The stock had previously closed at $29.96.
Wall Street Analyst Weigh In
Separately, Weiss Ratings restated a "hold (c)" rating on shares of Smith-Midland in a research note on Monday, December 29th. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, Smith-Midland has an average rating of "Hold".
Get Our Latest Report on SMID
Smith-Midland Stock Performance
The company has a current ratio of 2.76, a quick ratio of 2.33 and a debt-to-equity ratio of 0.08. The stock has a market cap of $157.15 million, a PE ratio of 13.36 and a beta of 1.81. The business's 50-day moving average price is $34.67 and its 200-day moving average price is $35.78.
Hedge Funds Weigh In On Smith-Midland
Large investors have recently made changes to their positions in the business. CWM LLC boosted its position in shares of Smith-Midland by 1,300.0% in the 3rd quarter. CWM LLC now owns 1,064 shares of the company's stock worth $39,000 after purchasing an additional 988 shares in the last quarter. Tower Research Capital LLC TRC increased its position in Smith-Midland by 495.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,787 shares of the company's stock valued at $60,000 after buying an additional 1,487 shares in the last quarter. Wells Fargo & Company MN increased its position in Smith-Midland by 75.5% during the 4th quarter. Wells Fargo & Company MN now owns 3,039 shares of the company's stock valued at $110,000 after buying an additional 1,307 shares in the last quarter. Rhumbline Advisers raised its stake in Smith-Midland by 9.6% in the first quarter. Rhumbline Advisers now owns 4,265 shares of the company's stock valued at $133,000 after buying an additional 372 shares during the last quarter. Finally, Barclays PLC raised its stake in Smith-Midland by 8.6% in the fourth quarter. Barclays PLC now owns 4,224 shares of the company's stock valued at $154,000 after buying an additional 335 shares during the last quarter. 49.94% of the stock is owned by institutional investors and hedge funds.
About Smith-Midland
(
Get Free Report)
Smith-Midland Corporation NASDAQ: SMID is a Virginia‐based manufacturer specializing in precast and cast‐in‐place concrete products for use in residential, commercial and infrastructure applications. Headquartered in Midland, Virginia, the company operates a primary production facility where it designs, engineers and produces a wide array of concrete components under stringent quality controls. Smith‐Midland's products are widely used by builders, contractors and government agencies across the United States.
The company's Construction Products Group offers an extensive portfolio of engineered solutions for transportation and site development projects.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Smith-Midland, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith-Midland wasn't on the list.
While Smith-Midland currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.